Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

Cirrhosis I: Introduction

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluation of Serum Zonulin Level and Intestinal Permeability in Patients with Chronic Spontaneous Urticaria and the Relationship Between Serum Zonulin Level and Disease Severity.

Dermatology practical & conceptual·2025

Same author

Exploring EGPA: Clinical perspectives on peripheral eosinophilia and lung involvement with real-life data.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2025

Same author

Sleep quality in patients with chronic spontaneous urticaria and relation with Orexin-A, leptin, and ghrelin.

Allergy and asthma proceedings·2024

Same author

A challenging issue in COVID-19 infection: The relationship between PA1-1 and TAFI levels in patients with coagulation disorder: A retrospective and observational study.

Medicine·2024

Same author

The role of orexin in fatigue and sleep quality in patients with primary Sjögren's syndrome.

Zeitschrift fur Rheumatologie·2023

Same author

The Relationship between the Number of Manic Episodes and Oxidative Stress Indicators in Bipolar Disorder.

Psychiatry investigation·2018

Search research articles

Related Experiment Video

Updated: Apr 20, 2026

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

Red cell distribution width and nonalcoholic steatohepatitis.

Yasemin Gulcan Kurt¹, Tuncer Cayci¹, Fevzi Nuri Aydin¹

¹Yasemin Gulcan Kurt, Tuncer Cayci, Department of Biochemistry, Gulhane Military Medical Academy, 06010 Ankara, Turkey.

World Journal of Gastroenterology

|December 5, 2014

Summary

Red cell distribution width (RDW) indicates red blood cell size variation and aids in diagnosing anemia. Elevated RDW may signal inflammation, potentially linking it to nonalcoholic steatohepatitis, but requires evaluating inflammatory markers.

Keywords:

Fibrosis Inflammatory markers Red cell distribution width Steatohepatitis Steatosis

More Related Videos

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH

Published on: April 20, 2021

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Related Experiment Videos

Last Updated: Apr 20, 2026

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH

Published on: April 20, 2021

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Area of Science:

Hematology
Hepatology
Inflammation research

Background:

Red cell distribution width (RDW) quantifies red blood cell volume variation, serving as a diagnostic marker for anemia and anisocytosis.
Elevated RDW levels are recognized indicators of acute and chronic inflammatory conditions.
Nonalcoholic steatohepatitis (NASH) is characterized by hepatic steatosis and inflammation.

Discussion:

The study explores the potential of RDW as a biomarker for nonalcoholic steatohepatitis (NASH).
Inflammation is a key component of NASH, and RDW's association with inflammatory responses suggests a possible link.
Evaluating confounding factors, particularly inflammatory markers, is crucial for validating RDW's role in NASH.

Key Insights:

RDW reflects red blood cell heterogeneity and is linked to inflammatory processes.
NASH involves inflammation, making RDW a candidate marker for investigation.
The utility of RDW in NASH diagnosis is contingent on accounting for other inflammatory markers.

Outlook:

Further research is needed to establish RDW as a reliable biomarker for NASH.
Investigating the correlation between RDW, inflammatory markers, and NASH severity is warranted.
This could lead to novel, non-invasive diagnostic approaches for liver disease.